Document is current
Any future updates will be listed below
-
Authors
Merki-Feld, Gabriele https://orcid.org/0000-0002-8644-773X
Dietrich, Hanna
Imesch, Patrick
Gantenbein, Andreas R.
Sandor, Peter
Schankin, Christoph J.
-
Funding
Funding for this research was provided by:
University of Zurich
- License Information
-
More Information
Article History
Received: 25 July 2023
Accepted: 22 January 2024
First Online: 15 June 2024
Declarations
:
: GSM: Reports fee for advisory board and presentations for/from Novartis, Eli Lilly, Almirall Lundbeck. CJS: Reports fees for consulting, advisory boards, presentations, and travel support for/from Novartis, Eli Lilly, TEVA Pharmaceuticals, Pfizer, Allergan, Abbvie, Almirall, Amgen, Lundbeck, MindMed, Grünenthal. He is part-time-employee at Zynnon. He has received research support from Swiss Heart Foundation, Eye on Vision Foundation, Baasch-Medicus Foundation, German Migraine and Headache Society, Visual Snow Syndrome Germany e.V. ARG has received honoraria for speaking or consulting from Amgen, Abbvie, Allergan, Biomed, Curatis, EliLilly, Lundbeck, Novartis, Sanofi and TEVA. PS has received honoraria for advisory boards from Novartis, Eli Lilly, Almirall. HD declares no CO. PI declares no COI.
